This topic contains a solution. Click here to go to the answer

Author Question: Which of the following statements about degeneracy pressure is not true? A) Degeneracy pressure ... (Read 22 times)

nenivikky

  • Hero Member
  • *****
  • Posts: 516
Which of the following statements about degeneracy pressure is not true?
 
  A) Degeneracy pressure keeps any protostar less than 0.08 solar mass from becoming a true, hydrogen-fusing star.
  B) Degeneracy pressure can halt gravitational contraction of a star even when no fusion is occurring in the core.
  C) Degeneracy pressure is a consequence of the laws of quantum mechanics.
  D) Degeneracy pressure varies with the temperature of the star.

Question 2

We have direct experimental evidence (from large particle accelerators) for the physical conditions in the universe back to about ________ after the Big Bang.
 
  A) 3 minutes
  B) 10-10 seconds
  C) 1 million years
  D) 380,000 years
  E) 300 years



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

gcook

  • Sr. Member
  • ****
  • Posts: 343
Answer to Question 1

D

Answer to Question 2

B




nenivikky

  • Member
  • Posts: 516
Reply 2 on: Jul 27, 2018
Gracias!


Bigfoot1984

  • Member
  • Posts: 321
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

In 2010, opiate painkllers, such as morphine, OxyContin®, and Vicodin®, were tied to almost 60% of drug overdose deaths.

Did you know?

The average adult has about 21 square feet of skin.

Did you know?

Many supplement containers do not even contain what their labels say. There are many documented reports of products containing much less, or more, that what is listed on their labels. They may also contain undisclosed prescription drugs and even contaminants.

Did you know?

On average, someone in the United States has a stroke about every 40 seconds. This is about 795,000 people per year.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library